Get started
Author

Silke Baasner

Synthetic 2-Aroylindole Derivatives as a New Class of Potent Tubulin-Inhibitory, Antimitotic Agents
2001 · Siavosh Mahboobi, Herwig Pongratz, et al. · Journal of Medicinal Chemistry · 106
Bis(1 H -2-indolyl)methanones as a Novel Class of Inhibitors of the Platelet-Derived Growth Factor Receptor Kinase
2002 · Siavosh Mahboobi, Steffen Teller, et al. · Journal of Medicinal Chemistry · 82
Sulfonate Derivatives of Naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-Anthracenone as Highly Active Antimicrotubule Agents. Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization
2007 · Anne Zuse, Peter Schmidt, et al. · Journal of Medicinal Chemistry · 52
Clinical significance and risk factors for new onset and recurring atrial fibrillation following cardiac surgery - a retrospective data analysis
2017 · Hristo Todorov, Inka Janssen, et al. · BMC Anesthesiology · 47
PDF
Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.
2003 · Ilka B Schiffer, Susanne Gebhard, et al. · PubMed · 42
Reversible tumorigenesis in mice by conditional expression of the HER2/c-erbB2 receptor tyrosine kinase.
1996 · S Baasner, H von Melchner, et al. · PubMed · 30
10-(2-oxo-2-Phenylethylidene)-10H-anthracen-9-ones as Highly Active Antimicrotubule Agents: Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization
2009 · Helge Prinz, Peter Schmidt, et al. · Journal of Medicinal Chemistry · 27
9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as Novel Antimicrotubule AgentsSynthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization
2006 · Anne Zuse, Peter Schmidt, et al. · Journal of Medicinal Chemistry · 26
Synthesis, antiproliferative activity and inhibition of tubulin polymerization by 1,5- and 1,8-disubstituted 10H-anthracen-9-ones bearing a 10-benzylidene or 10-(2-oxo-2-phenylethylidene) moiety
2010 · Holger C. Nickel, Peter Schmidt, et al. · European Journal of Medicinal Chemistry · 23
Fully Balanced Fluids do not Improve Microvascular Oxygenation, Acidosis and Renal Function in a Rat Model of Endotoxemia
2016 · Bulent Ergin, Lara Zafrani, et al. · Shock · 22
Differentiated control of deranged nitric oxide metabolism: a therapeutic option in sepsis?
2013 · Corinna Lupp, Silke Baasner, et al. · Critical Care · 22
PDF
Synthesis and structure–activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents
2009 · Pascal Marchand, Maud Antoine, et al. · Bioorganic & Medicinal Chemistry · 21
Phenylimino-10H-anthracen-9-ones as novel antimicrotubule agents—synthesis, antiproliferative activity and inhibition of tubulin polymerization
2011 · Helge Prinz, Peter Schmidt, et al. · Bioorganic & Medicinal Chemistry · 18
Design and Synthesis of a Focused Library of Novel Aryl‐ and Heteroaryl‐Ketopiperazides
2004 · Matthias Gerlach, Eckhard Claus, et al. · Archiv der Pharmazie · 7
Side chain modifications of (indol-3-yl)glyoxamides as antitumor agents
2008 · Maud Antoine, Pascal Marchand, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2
PDF
4-Substituted-piperazin-1-yl-carbonyl-pyrazol derivatives: A new class of highly potent cytotoxic compounds with inhibitory effects on tubulin polymerization
2004 · Silke Baasner, Matthias Gerlach, et al. · Cancer Research · 1
Manipulation of Nitric Oxide Levels via a Modified Hydroxyethyl Starch Molecule
2022 · Ugur Aksu, Can Ince, et al. · Journal of Surgical Research
Implementation of Measurable and Sustainable Actions to Improve Employee’s Engagement and Business Performance: Global Medical Clinical & Regulatory Affairs (GMCRA) – A Role Model at Fresenius Kabi
2020 · Silke Baasner · Springer eBooks
PDF
MON-LB286: Intravenous Glutamine Infusion is not Toxic in a Rat Model of Moderate Kidney Injury
2016 · M.K. Bothe, R. Abele, et al. · Clinical Nutrition
Abstract 4587: Combined administration of Voluven® 10% and anti-cancer drugs increases anti-tumor efficacy
2014 · Silke Baasner, Corinna Lupp, et al. · Cancer Research
Abstract 5546: Coupling of hydroxyethyl starch to anticancer drugs for the improvement of tolerability and efficacy.
2013 · Silke Baasner, Corinna Lupp, et al. · Cancer Research
Manipulation of nitric oxide levels with a modified hydroxyethyl starch molecule
2012 · C Lupp, S Baasner, et al. · Critical Care
PDF
Abstract 937: Dose-banding of docetaxel in MT-3 tumor bearing nude mice
2012 · Silke Baasner, Christoph Meyer, et al. · Cancer Research
CCDC 750013: Experimental Crystal Structure Determination
2012 · Nickel, H.C., Schmidt, P., et al. · The Cambridge Structural Database
197 AEZS-132, a new orally bioavailable PI3K/Erk inhibitor with antitumor effects
2010 · I. Seipelt, M. Gerlach, et al. · European Journal of Cancer Supplements
Works count: 37
Citation count: 528
H-index: 13
I10-index: 13
Year
Topic
Type